Pharmacyte Biotech, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
PharmaCyte Biotech reports 74.00% beneficial ownership of Q/C Technologies via preferred stock and warrants following shareholder approval.